Medical Imaging Convention [rescheduled] Sep 15, 2021 - Sep 16, 2021 — National Exhibition Centre, Birmingham, England
2021 SINAPSE ASM Sep 16, 2021 - Sep 17, 2021 — Technology & Innovation Centre, University of Strathclyde, 99 George Street, Glasgow
Total Body PET 2021 conference [rescheduled] Sep 22, 2021 - Sep 24, 2021 — Virtual Meeting (online)
PET is Wonderful Annual Meeting 2021 Oct 26, 2021 12:00 AM — Virtual Meeting (online)

eLearning

SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists.


Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas

Author(s): G. H. Bain, E. Collie-Duguid, G. I. Murray, F. J. Gilbert, A. Denison, F. McKiddie, T. Ahearn, I. Fleming, J. Leeds, P. Phull, K. Park, S. Nanthakumaran, H. I. Grabsch, P. Tan, A. Welch, L. Schweiger, A. Dahle-Smith, G. Urquhart, M. Finegan, R. D. Petty

Abstract:
BACKGROUND: Cytotoxic chemotherapy remains the main systemic therapy for gastro-oesophageal adenocarcinoma, but resistance to chemotherapy is common, resulting in ineffective and often toxic treatment for patients. Predictive biomarkers for chemotherapy response would increase the probability of successful therapy, but none are currently recommended for clinical use. We used global gene expression profiling of tumour biopsies to identify novel predictive biomarkers for cytotoxic chemotherapy. METHODS: Tumour biopsies from patients (n=14) with TNM stage IB-IV gastro-oesophageal adenocarcinomas receiving platinum-based combination chemotherapy were used as a discovery cohort and profiled with Affymetrix ST1.0 Exon Genechips. An independent cohort of patients (n=154) treated with surgery with or without neoadjuvant platinum combination chemotherapy and gastric adenocarcinoma cell lines (n=22) were used for qualification of gene expression profiling results by immunohistochemistry. A cisplatin-resistant gastric cancer cell line, AGS Cis5, and the oesophageal adenocarcinoma cell line, OE33, were used for in vitro validation investigations. RESULTS: We identified 520 genes with differential expression (Mann-Whitney U, P<0.020) between radiological responding and nonresponding patients. Gene enrichment analysis (DAVID v6.7) was used on this list of 520 genes to identify pathways associated with response and identified the adipocytokine signalling pathway, with higher leptin mRNA associated with lack of radiological response (P=0.011). Similarly, in the independent cohort (n=154), higher leptin protein expression by immunohistochemistry in the tumour cells was associated with lack of histopathological response (P=0.007). Higher leptin protein expression by immunohistochemistry was also associated with improved survival in the absence of neoadjuvant chemotherapy, and patients with low leptin protein-expressing tumours had improved survival when treated by neoadjuvant chemotherapy (P for interaction=0.038). In the gastric adenocarcinoma cell lines, higher leptin protein expression was associated with resistance to cisplatin (P=0.008), but not to oxaliplatin (P=0.988) or 5fluorouracil (P=0.636). The leptin receptor antagonist SHLA increased the sensitivity of AGS Cis5 and OE33 cell lines to cisplatin. CONCLUSIONS: In gastro-oesophageal adenocarcinomas, tumour leptin expression is associated with chemoresistance but a better therapy-independent prognosis. Tumour leptin expression determined by immunohistochemistry has potential utility as a predictive marker of resistance to cytotoxic chemotherapy, and a prognostic marker independent of therapy in gastro-oesophageal adenocarcinoma. Leptin antagonists have been developed for clinical use and leptin and its associated pathways may also provide much needed novel therapeutic targets for gastro-oesophageal adenocarcinoma.

Full version: Available here

Click the link to go to an external website with the full version of the paper


ISBN: 1532-1827 (Electronic) 0007-0920 (Linking)
Publication Year: 2014
Periodical: Br J Cancer
Periodical Number: 6
Volume: 110
Pages: 1525-34
Author Address: 1] Institute of Medical Sciences, School of Medicine and Dentistry, University of Aberdeen, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK [2] Department of Gastroenterology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK. Institute of Medical Sciences, School of Medicine and Dentistry, University of Aberdeen, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK. 1] Institute of Medical Sciences, School of Medicine and Dentistry, University of Aberdeen, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK [2] Department of Pathology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK. Department of Radiology, Medical School, University of Cambridge, Cambridge CB2 0QQ, UK. 1] Institute of Medical Sciences, School of Medicine and Dentistry, University of Aberdeen, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK [2] Department of Radiology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK [3] Department of Nuclear Medicine, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK. Department of Nuclear Medicine, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK. Department of Gastroenterology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK. Department of Surgery, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK. Section of Pathology and Tumour Biology, Leeds Institute of Cancer Studies and Pathology, University of Leeds, Leeds, UK. Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. 1] Institute of Medical Sciences, School of Medicine and Dentistry, University of Aberdeen, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK [2] Department of Oncology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill, Aberdeen, Scotland AB25 2ZN, UK.